Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Radioconjugates targeting CD33 in the treatment of sarcomas

Radioconjugates targeting CD33 in the treatment of sarcomas

US Patent 12491274 · Granted Dec 9, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Radioconjugates directed to MHC-complexed antigens in cancer2025
Anti-CD45-based conditioning methods and uses thereof in conjunction with gene-e2024
Anti-PD-L1-anti-TIM-3 bispecific antibodies2022
Checkpoint inhibitor bispecific antibodies2021
Anti-canine platelet derived growth factor receptor alpha antibody2020
Anti-PD-L1-anti-TIM-3 bispecific antibodies2019
PD-L1 antibodies2019
Compounds to fibroblast growth factor receptor-3 (FGFR3) and methods of treatmen2016
IGF-IR antagonists as adjuvants for treatment of prostate cancer2011
Fully human antibodies directed against the human insulin-like growth factor-1 r2011
Apelin and uses thereof2011
Fully human antibodies directed against the human insulin-like growth factor-1 r2009